title: Strategy of Infection Control in Immunosuppressive Therapy for ANCA-Associated Vasculitis.
abstract: Antineutrophil cytoplasmic antibodies (ANCA) are well known to be associated with small vessel vasculitic diseases such as microscopic polyangiitis (MPA), allergic granulomatous angiitis (AGA), and Granulomatosis with poly angiitis: GPA (Wegener's). Disease assessment by 1) vasculitic activity, 2) damage resulting from vasculitis, and 3) patient function, were the required endpoints for the therapeutic trials in ANCA-associated vasculitis (AAV). Harmonized steroids and cyclophosphamide or azathioprine are effective for active AAV. In evaluating tools for monitoring disease, titers of ANCA and the levels of CRP were found useful in AAV. However, it will be important for clinicians to observe AAV patients more closely and reduce immunosuppressive drug doses more cautiously, especially to prevent several infections (i.e., deep mycosis, pneumocystis jirovecii pneumonia and cytomegalovirus). We indicated that strategy of infection control in immunosuppressive therapy for AAV. (J Jpn Coll Angiol, 2009, 49: 93-99).
authors: Renal Unit of Internal Medicine, Hachioji Medical Center of Tokyo Medical University, Tokyo, Japan.
authors: Masaharu
authors: M
authors: Yoshida
keywords: ANCA associated vasculitis; compromized host; immunosuppressive therapy; infection control
references: N Engl J Med. 1996 Jul 4;335(1):16-20
references: 8637536
references: Nihon Naika Gakkai Zasshi. 2001 Sep 10;90(9):1702-7
references: 11681046
references: Mod Rheumatol. 2012 Jun;22(3):394-404
references: 21928092
references: Biol Pharm Bull. 2005 May;28(5):773-8
references: 15863877
references: FEMS Immunol Med Microbiol. 2005 Apr 1;44(1):99-109
references: 15780582
references: Clin Rheumatol. 2009 May;28(5):565-71
references: 19190977
references: Arthritis Rheum. 2000 May;43(5):1021-32
references: 10817555